Successful conservative treatment of a case of mandibular osteomyelitis in a patient with pycnodysostosis

Pycnodysostosis, first described by Maroteaux and Lamy in 1962, is a rare autosomal recessive disease characterized by generalized diffuse bone sclerosing, short stature, and bone fragility, occurring frequently in association with skeletal dysplasia. Complications of pycnodysostosis such as intractable maxillary and mandibular osteomyelitis are common and appear in various forms. We present a case of mandibular osteomyelitis in a patient with pycnodysostosis who responded successfully to 7 years of conservative treatment. A 48-year-old woman who was previously given a diagnosis of pycnodysostosis was referred to our hospital because of continuous swelling and pain around the mandibular left first molar. Osteomyelitis gradually progressed after removal of the first molar. After a long follow-up period, during which the patient received local irrigation and low-dose antibiotic therapy, sequestration occurred. The lesion was cured completely by additional application of hyperbaric oxygen therapy (20 sessions). Even after 10 months of follow up, there has been no recurrence of inflammation.

[1]  Sheila Unger,et al.  Nosology and Classification of Genetic Skeletal Disorders: 2010 Revision , 2011, American journal of medical genetics. Part A.

[2]  P. Bougnères,et al.  Near normalization of adult height and body proportions by growth hormone in pycnodysostosis. , 2010, The Journal of clinical endocrinology and metabolism.

[3]  J. Eisman,et al.  Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  K. Brix,et al.  Cysteine cathepsins: cellular roadmap to different functions. , 2008, Biochimie.

[5]  C. Ungari,et al.  Ozone Therapy in the Treatment of Avascular Bisphosphonate-Related Jaw Osteonecrosis , 2007, The Journal of craniofacial surgery.

[6]  N. Kato,et al.  Mandibular osteomyelitis and fracture successfully treated with vascularised iliac bone graft in a patient with pycnodysostosis. , 2005, British journal of plastic surgery.

[7]  T. Kirita,et al.  Mandibular reconstruction using a vascularised fibula osteocutaneous flap in a patient with pyknodysostosis. , 2001, British journal of plastic surgery.

[8]  J. Risteli,et al.  Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. , 2000, Bone.

[9]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jian Zhang,et al.  Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. , 1996, Biochemical and molecular medicine.

[11]  T. Tomomitsu,et al.  Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding study , 2013, Osteoporosis International.

[12]  茶木 修 The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women , 2001 .